MedTrace Logo

Endocrine Dysfunction and Quality of Life After Subarachnoid Hemorrhage

NCT01101711 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2012-09-07

No results posted yet for this study

Summary

Investigation of the incidence of endocrine dysfunction following subarachnoid hemorrhage (SAH), and to see if this has a relation to CNS lesions as evaluated by MRI and to common symptoms after SAH such as general exhaustion, lack of initiative, increased sleep demand and reduced quality of life.

Conditions

  • Endocrine Dysfunction
  • Cerebral Infarctions
  • Quality of Life

Sponsors & Collaborators

  • Lund University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2011-02-28
Completion
2012-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01101711 on ClinicalTrials.gov